Wolfram Brugger
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Hematology 68
- Hematopoietic Stem Cell Transplantation 32
- Acute Myeloid Leukemia Research 25
- Multiple Myeloma Research and Treatments 8
- Immunology 35
- Immunotherapy and Immune Responses 24
- Immune cells in cancer 11
- Co-authors
- Lothar Kanz (86 shared papers)Peter Brossart (26 shared papers)Gernot Stuhler (9 shared papers)Frank Grünebach (16 shared papers)Volker L. Reichardt (9 shared papers)Robert Möhle (6 shared papers)Hans‐Jörg Bühring (12 shared papers)Stefan Wirths (6 shared papers)
- Journals
- Blood (50 papers)Annals of Oncology (13 papers)Experimental Hematology (6 papers)Journal of Clinical Oncology (6 papers)British Journal of Haematology (5 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Wolfram Brugger
178 papers receiving 11.7k citations
Wolfram Brugger's Hit Papers
Peers
Comparison fields: 5 of 113
- Hematology 2.2k
- Immunology 3k
- Pathology and Forensic Medicine 1.7k
- Genetics 730
- Oncology 1.5k
Countries citing papers authored by Wolfram Brugger
This map shows the geographic impact of Wolfram Brugger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram Brugger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram Brugger more than expected).
Fields of papers citing papers by Wolfram Brugger
This network shows the impact of papers produced by Wolfram Brugger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram Brugger. The network helps show where Wolfram Brugger may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolfram Brugger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial Hit paper breakdown → | 2013 | 1180 |
| 2 | Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study Hit paper breakdown → | 2010 | 990 |
| 3 | Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Hit paper breakdown → | 2012 | 686 |
| 4 | 1998 | 562 | |
| 5 | 2000 | 467 | |
| 6 | 2011 | 337 | |
| 7 | 1999 | 272 | |
| 8 | 1999 | 267 | |
| 9 | 2011 | 232 | |
| 10 | 2010 | 213 | |
| 11 | 2011 | 205 | |
| 12 | 2012 | 200 | |
| 13 | 2010 | 193 | |
| 14 | Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. | 1998 | 192 |
| 15 | Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. | 2003 | 192 |
| 16 | 2006 | 192 | |
| 17 | 1990 | 191 | |
| 18 | The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. | 2001 | 180 |
| 19 | 2002 | 180 | |
| 20 | Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. | 1990 | 177 |
About Wolfram Brugger
Wolfram Brugger is a scholar working on Hematology, Immunology, Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 183 papers that have together received 12.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (32 papers), Acute Myeloid Leukemia Research (25 papers), Lymphoma Diagnosis and Treatment (24 papers), Immunotherapy and Immune Responses (24 papers), Immune cells in cancer (11 papers), Lung Cancer Treatments and Mutations (10 papers), Neutropenia and Cancer Infections (9 papers) and Multiple Myeloma Research and Treatments (8 papers). The work is most often cited by research in Hematology (2.2k citations), Immunology (3k citations), Pathology and Forensic Medicine (1.7k citations), Genetics (730 citations) and Oncology (1.5k citations). Wolfram Brugger has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Lothar Kanz, Peter Brossart, Gernot Stuhler, Frank Grünebach, Volker L. Reichardt, Robert Möhle, Hans‐Jörg Bühring, Stefan Wirths, Frank Bautz and Federico Cappuzzo. Their work appears in journals such as Blood, Annals of Oncology, Experimental Hematology, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.